Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Young adults can benefit from starting retirement planning early. Discover the best retirement plans tailored for your age group.
24,827 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A Portland, Oregon court filing shows Compass has settled the Murch TCPA lawsuit. The terms are confidential, and a n...
MSCI pushes Indonesia’s market status review to November 2026, signaling patience amid ongoing reforms and watchful g...
Trump abruptly delays signing the 21st Century ROAD to Housing Act, tying its fate to passage of the SAVE AMERICA ACT...
A long-time investor explains why AbbVie’s mix of rapidly growing immunology drugs and a dependable dividend keeps dr...
Two defendants, Real Brokerage and The Frano Team, were voluntarily dismissed without prejudice from the Taylor RESPA...
FuelCell Energy leads a sell-off in fuel-cell stocks as investors lock in gains after a sharp rally, while Bloom Ener...
Bitcoin hovered near the $60,000 mark but briefly slid toward $58,000 as ETF outflows intensified and inflation data ...
Sezzle's CEO argues BNPL market gains are siphoning wallet share from traditional lenders as the fintech reports stro...
XRP is under renewed pressure after a harsh stretch of declines, with traders weighing the risk of deeper losses agai...
The Supreme Court declined to hear Alan Dershowitz's $300 million defamation suit against CNN, ending a high-profile ...
Investors are racing to price in the first real revenue opportunities from quantum tech as a new federal funding push...